Can Kawasaki disease be cured?

Written by Li Jiao Yan
Neonatology
Updated on September 05, 2024
00:00
00:00

Kawasaki disease, also known as mucocutaneous lymph node syndrome, has an unclear pathogenesis. The primary pathological change is systemic vasculitis. It commonly affects infants and young children, with 80% of cases occurring in children under five years of age. Kawasaki disease is a self-limiting condition, and most cases have a good prognosis. However, there is a 1% to 2% chance of recurrence. If not effectively treated, 15% to 25% of cases may develop coronary artery aneurysms. These aneurysms often resolve on their own within two years after the disease, but often leave behind abnormalities such as thickening of the vessel wall and decreased elasticity. Larger aneurysms may not completely resolve and can lead to thrombosis or narrowing of the vessel. Kawasaki disease is also one of the causes of acquired heart disease in children. Therefore, Kawasaki disease should be treated promptly and effectively to prevent severe complications.

Other Voices

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
53sec home-news-image

The recurrence rate of Kawasaki disease

Kawasaki disease, also known as mucocutaneous lymph node syndrome, is a type of pediatric autoimmune disease that commonly affects infants and young children, especially those under the age of five. The exact mechanisms and causes of the disease are still unclear. The primary pathological change is systemic vasculitis, frequently affecting the coronary arteries. The recurrence rate of Kawasaki disease is between 1%-3%, with a few cases experiencing three or even four occurrences. The interval between recurrences ranges from three months to one year, averaging one year and five months. Studies have shown that being younger than three years old at the time of the first episode and having vascular damage are risk factors for recurrence.

doctor image
home-news-image
Written by Yan Xin Liang
Pediatrics
52sec home-news-image

Is Kawasaki disease characterized by eye discharge?

Kawasaki disease is an autoimmune vasculitis that can affect blood vessels throughout the body and various organs, but the most severe impact is typically on the coronary arteries, which can lead to dilation of the coronary arteries or the possibility of forming coronary artery aneurysms. The disease can cause conjunctival congestion, but this is a manifestation of aseptic conjunctivitis, meaning it does not cause, nor does it result in, purulent secretions, in other words, it does not cause eye discharge. Therefore, if a patient with Kawasaki disease has purulent eye discharge, it is possible that they have a concurrent bacterial conjunctivitis. Thus, generally, eyes affected by Kawasaki disease do not have eye discharge but may appear dry and red.

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
42sec home-news-image

How long to take aspirin for Kawasaki disease

The current pathogenesis of Kawasaki disease is not yet clear, but one of its main pathological changes is a systemic vasculitis. During an outbreak of Kawasaki disease, the blood viscosity increases primarily due to platelet aggregation. Typically, oral aspirin is administered to prevent this inflammation and to treat platelet aggregation. The dosage is generally reduced gradually once the fever subsides, with maintenance doses lasting about six to eight weeks. If coronary artery lesions are present, the duration of medication is extended until the coronary arteries return to normal before discontinuing the drug.

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
1min 14sec home-news-image

Can Kawasaki disease be cured?

Kawasaki disease, also known as mucocutaneous lymph node syndrome, has an unclear pathogenesis. The primary pathological change is systemic vasculitis. It commonly affects infants and young children, with 80% of cases occurring in children under five years of age. Kawasaki disease is a self-limiting condition, and most cases have a good prognosis. However, there is a 1% to 2% chance of recurrence. If not effectively treated, 15% to 25% of cases may develop coronary artery aneurysms. These aneurysms often resolve on their own within two years after the disease, but often leave behind abnormalities such as thickening of the vessel wall and decreased elasticity. Larger aneurysms may not completely resolve and can lead to thrombosis or narrowing of the vessel. Kawasaki disease is also one of the causes of acquired heart disease in children. Therefore, Kawasaki disease should be treated promptly and effectively to prevent severe complications.

doctor image
home-news-image
Written by Yao Li Qin
Pediatrics
50sec home-news-image

What is Kawasaki disease? Is it contagious?

Kawasaki disease is a common pediatric febrile rash disease, also known as mucocutaneous lymph node syndrome. It is a systemic vasculitis syndrome mediated by immune mechanisms. Kawasaki disease may be caused by acute immune dysregulation due to infectious factors, and genetic factors may be related to the acute onset of the disease. Therefore, Kawasaki disease is not contagious, and contact with children with Kawasaki disease will not lead to transmission. Kawasaki disease generally occurs in infants and young children, and there is no clear seasonal pattern to its occurrence, nor significant gender differences.